---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-031105"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T01:37:22.838422+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions acquires IFP, reports Q1 net loss of $1.21M, cash $5.74M

## Summary
- Acquired Intelligent Fingerprinting Limited (IFP) for its sweat-based fingerprint drug screening technology.
- Net loss $1.21M ($0.08 per share) vs $1.43M ($0.10) prior year; cash $5.74M as of Sept 30, 2022.
- New customer wins: Goldstar Transport, Eastern Airways, and Glass Systems Group adopted IFP drug test.
- Board additions: David Jenkins (CEO of Catheter Precision) and Jason Isenberg appointed in October.
- Cash runway expected into first half of calendar 2023; excludes potential new market revenue.

## SEC filing metadata
- accession: 0001493152-22-031105
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315222031105/0001493152-22-031105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315222031105/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-031105
- JSON: https://secwatch.observer/filing/0001493152-22-031105.json
- Plain text: https://secwatch.observer/filing/0001493152-22-031105.txt

## Key facts
- Earnings Releases
  INTELLIGENT BIO SOLUTIONS INC. reported preliminary financial results for first financial quarter ended September 30, 2022.
  - Period: first financial quarter ended September 30, 2022
  - Result: preliminary results
  source text: On November 9, 2022, Intelligent Bio Solutions Inc. (the “Company”), issued a press release (the “Press Release”) announcing financial results for the three months ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315222031105/0001493152-22-031105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.